Preclinical – ClinicReady
ClinicReady is the surrogate or outsourced drug development team for preclinical biotechs.
ClinicReady is the surrogate or outsourced drug development team for preclinical biotechs.
Avance Clinical exhibits at ASN Kidney Week 2026, Booth 234. Discuss renal & cardiometabolic trial design and global patient access. Book a meeting
Avance Clinical's CNS Center of Excellence joins CNS Therapeutics Xchange San Francisco 2026 to tackle screen failure and attrition in CNS trials.
We’re excited to announce that Avance Clinical will be exhibiting at the 2026 BIO International Convention in San Diego (June 22–25, 2026) - the must-attend global gathering for the biotech industry.
Avance Clinical is excited to announce our participation in SCOPE Summit 2026, one of the most influential gatherings in clinical operations, where leading innovators in biotech, pharma, CROs, and technology come together to share strategies shaping the future of global drug development.
In a recent video interview with Applied Clinical Trials, Ben Edwards, Chief Operating Officer, Avance Clinical, discussed common challenges in biotech, emphasizing the importance of addressing preclinical package gaps to avoid delays.
Avance Clinical will be attending the 17th Annual Outsourcing in Clinical Trials New England 2025.
This presentation outlines the key success factors driving high-impact oncology drug development, with a focus on translating innovative science into clinically and commercially meaningful outcomes.
Avance Clinical has signed a Memorandum of Understanding (MOU) with Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH), a top-tier clinical research hospital in Taiwan, recognized for its excellence in conducting high-quality clinical trials and its leadership in medical innovation.